help button home button Am J Pathol The FASEB Journal
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gan, Y.-J.
Right arrow Articles by Sixbey, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gan, Y.-J.
Right arrow Articles by Sixbey, J. W.
(American Journal of Pathology. 2002;160:781-786.)
© 2002 American Society for Investigative Pathology

Short Communication

A Defective, Rearranged Epstein-Barr Virus Genome in EBER-Negative and EBER-Positive Hodgkin’s Disease

Yan-Jun Gan*, Bassem I. Razzouk{dagger}, Tao Su* and John W. Sixbey*{ddagger}

From the Department of Microbiology andImmunology*
and the Feist-Weiller CancerCenter,{ddagger}
Louisiana State University HealthSciences Center, Shreveport, Louisiana; and St. Jude Children’sResearch Hospital,{dagger}
Memphis, Tennessee

A ubiquitous herpesvirus that establishes life-long infection, the Epstein-Barr virus (EBV) has yielded little insight into how a single agent in general accord with its host can produce diverse pathologies ranging from oral hairy leukoplakia to nasopharyngeal carcinoma, from infectious mononucleosis to Hodgkin’s disease (HD) and Burkitt’s lymphoma. Its pathogenesis is further confounded by the less than total association of virus with histologically similar tumors. In other viral systems, defective (interfering) viral genomes are known to modulate outcome of infection, with either ameliorating or intensifying effects on disease processes initiated by prototype strains. To ascertain whether defective EBV genomes are present in HD, we examined paraffin-embedded tissue from 56 HD cases whose EBV status was first determined by cytohybridization for nonpolyadenylated EBV RNAs (EBERs). Using both standard polymerase chain reaction (PCR) and PCR in situ hybridization, we successfully amplified sequences that span abnormally juxtaposed BamHI W and Z fragments characteristic of defective heterogeneous (het) EBV DNA from 10 of 32 (31%) EBER-positive tumors. Of 24 EBER-negative HD, 8 yielded PCR products indicating presence of het EBV DNA. Two of these contained defective EBV in the apparent absence of the prototype virus. Of the 42 tumors analyzed for defective EBV by both PCR techniques, there was concordance of results in 38 (90%). Detection of defective EBV genomes with the potential to disrupt viral gene regulation suggests one mechanism for pathogenic diversity that may also account for loss of prototypic EBV from individual tumor cells.




This article has been cited by other articles:


Home page
 J. Clin. Pathol.Home page
G Kapatai and P Murray
Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma
J. Clin. Pathol., December 1, 2007; 60(12): 1342 - 1349.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. M. Turk, R. Jiang, L. S. Chesnokova, and L. M. Hutt-Fletcher
Antibodies to gp350/220 Enhance the Ability of Epstein-Barr Virus To Infect Epithelial Cells
J. Virol., October 1, 2006; 80(19): 9628 - 9633.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
R. Jiang, R. S. Scott, and L. M. Hutt-Fletcher
Epstein-Barr Virus Shed in Saliva Is High in B-Cell-Tropic Glycoprotein gp42
J. Virol., July 15, 2006; 80(14): 7281 - 7283.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
J. L. Ryan, H. Fan, S. L. Glaser, S. A. Schichman, N. Raab-Traub, and M. L. Gulley
Epstein-Barr Virus Quantitation by Real-Time PCR Targeting Multiple Gene Segments: A Novel Approach to Screen for the Virus in Paraffin-Embedded Tissue and Plasma
J. Mol. Diagn., November 1, 2004; 6(4): 378 - 385.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
S. L. Glaser, J. L. Hsu, and M. L. Gulley
Epstein-Barr Virus and Breast Cancer: State of the Evidence for Viral Carcinogenesis
Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 688 - 697.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
E. A. Sisk, C. R. Bradford, T. E. Carey, A. Paulino, and E. Robertson
Epstein-Barr Virus Detected in a Head and Neck Squamous Cell Carcinoma Cell Line Derived From an Immunocompromised Patient
Arch Otolaryngol Head Neck Surg, October 1, 2003; 129(10): 1115 - 1124.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
C. A. Moody, R. S. Scott, T. Su, and J. W. Sixbey
Length of Epstein-Barr Virus Termini as a Determinant of Epithelial Cell Clonal Emergence
J. Virol., August 1, 2003; 77(15): 8555 - 8561.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
H. Knecht and B. F. Odermatt
Rearranged Epstein-Barr Virus Genome in Hodgkin's Disease and Angioimmunoblastic Lymphadenopathy: Swiss Results
Am. J. Pathol., July 1, 2003; 163(1): 369 - 370.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
B. G. Kelly, S. S. Lok, P. S. Hasleton, J. J. Egan, and J. P. Stewart
A Rearranged Form of Epstein-Barr Virus DNA Is Associated with Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med., August 15, 2002; 166(4): 510 - 513.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Society for Investigative Pathology.